USD 7.12
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 11.87 Billion CNY | 11.45% |
2022 | 10.65 Billion CNY | 76.43% |
2021 | 6.03 Billion CNY | 78.13% |
2020 | 3.38 Billion CNY | 44.79% |
2019 | 2.34 Billion CNY | -9.43% |
2018 | 2.58 Billion CNY | 76.96% |
2017 | 1.46 Billion CNY | 13.7% |
2016 | 1.28 Billion CNY | 66.47% |
2015 | 771.67 Million CNY | -10.47% |
2014 | 861.96 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 2.3 Billion CNY | 11.86% |
2024 Q3 | 2.81 Billion CNY | 1.58% |
2024 Q2 | 2.76 Billion CNY | 19.86% |
2023 Q2 | 3.79 Billion CNY | 45.18% |
2023 FY | 11.87 Billion CNY | 11.45% |
2023 Q1 | 2.61 Billion CNY | 44.49% |
2023 Q3 | 3.39 Billion CNY | -10.59% |
2023 Q4 | 2.06 Billion CNY | -39.18% |
2022 Q3 | 3.28 Billion CNY | -7.37% |
2022 Q1 | 2 Billion CNY | 15.53% |
2022 FY | 10.65 Billion CNY | 76.43% |
2022 Q2 | 3.54 Billion CNY | 77.03% |
2022 Q4 | 1.81 Billion CNY | -44.95% |
2021 FY | 6.03 Billion CNY | 78.13% |
2021 Q4 | 1.73 Billion CNY | 55.58% |
2021 Q2 | 1.48 Billion CNY | -12.27% |
2021 Q1 | 1.69 Billion CNY | 154.96% |
2021 Q3 | 1.11 Billion CNY | -25.1% |
2020 Q2 | 1.51 Billion CNY | 259.56% |
2020 Q1 | 420.24 Million CNY | 121.72% |
2020 Q3 | 792.41 Million CNY | -47.56% |
2020 FY | 3.38 Billion CNY | 44.79% |
2020 Q4 | 665.79 Million CNY | -15.98% |
2019 Q4 | 189.54 Million CNY | -78.07% |
2019 Q2 | 780.8 Million CNY | 54.23% |
2019 Q1 | 506.27 Million CNY | 21.75% |
2019 FY | 2.34 Billion CNY | -9.43% |
2019 Q3 | 864.3 Million CNY | 10.7% |
2018 Q1 | 365.31 Million CNY | 48.29% |
2018 FY | 2.58 Billion CNY | 76.96% |
2018 Q2 | 1.05 Billion CNY | 187.44% |
2018 Q4 | 415.83 Million CNY | -44.81% |
2018 Q3 | 753.5 Million CNY | -28.24% |
2017 FY | 1.46 Billion CNY | 13.7% |
2017 Q4 | 246.35 Million CNY | -30.21% |
2017 Q3 | 353.01 Million CNY | -27.36% |
2017 Q1 | 443.09 Million CNY | 0.0% |
2017 Q2 | 485.95 Million CNY | 9.67% |
2016 FY | 1.28 Billion CNY | 66.47% |
2015 FY | 771.67 Million CNY | -10.47% |
2014 FY | 861.96 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Bio Medica Corporation | -1.24 Million USD | 956000.637% |
Arrayit Corporation | -3.62 Million USD | 327835.733% |
Atlantic International Corp. | -5.73 Million USD | 207204.531% |
Biocept, Inc. | -31.98 Million USD | 37220.614% |
Bioqual, Inc. | -19.63 Thousand USD | 60455777.289% |
CardioGenics Holdings Inc | -772.14 Thousand USD | 1537678.05% |
DermTech, Inc. | -103.73 Million USD | 11544.381% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | -377.385% |
HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 57097.197% |
iMD Companies, Inc. | -175.44 Thousand USD | 6767017.403% |
IDenta Corp. | -1499.00 USD | 792013836.224% |
Interpace Biosciences, Inc. | 2.8 Million USD | -423305.346% |
Integrative Health Technologies, Inc. | 38.69 Thousand USD | -30685570.473% |
InVitro International | -25.33 Thousand USD | 46853906.014% |
Lumos Diagnostics Holdings Limited | -7.12 Million USD | 166798.763% |
Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 20430107.41% |
Medical Imaging Corp. | -819.48 Thousand USD | 1448858.47% |
NovelStem International Corp. | -3.52 Million USD | 336826.112% |
Optigenex Inc. | 1.39 Million USD | -853508.509% |
PharmChem, Inc. | 973.14 Thousand USD | -1219888.954% |
Proteome Sciences plc | -1.62 Million USD | 732505.053% |
Response Genetics, Inc | -21.37 Million USD | 55637.662% |
Rennova Health, Inc. | -1.4 Million USD | 842384.465% |
RushNet, Inc. | -684.7 Thousand USD | 1734027.152% |
ScreenPro Security Inc. | -2.59 Million USD | 458060.102% |
Stella Diagnostics Inc. | -11.42 Million USD | 103997.242% |
StageZero Life Sciences Ltd. | -7.74 Million USD | 153354.837% |
Todos Medical Ltd. | -9.74 Million USD | 121892.018% |